The result showed that attenuation of EMP3 expression markedly decreased the activities of TGF-β/Smad2/3 and NF-κB in all three GBM cell lines SF295, A172 and LN18 cells (Figure 3A). The gene discussed is NFKB1; the disease is glioblastoma.